Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Open Access
- 1 January 1996
- Vol. 51 (1) , 54-58
- https://doi.org/10.1136/thx.51.1.54
Abstract
BACKGROUND--The pathogenesis of dyspnoea in patients with chronic heart failure is poorly understood. Static lung compliance is reduced in chronic heart failure. The relation between static lung compliance and exercise capacity and dyspnoea in chronic heart failure has been investigated. METHODS--Static lung compliance was calculated from expiratory pressure-volume curves in 18 patients with chronic heart failure (three women, mean age 62 years). Catheter mounted pressure transducers were used to measure changes in oesophageal pressure. Changes in lung volume were determined by integrating flow at the mouth, measured by a pneumotachograph. New York Heart Association (NYHA) class for dyspnoea was determined by a single observer. Patients underwent treadmill exercise to symptom limited maximum using staged and fixed rate protocols. Borg ratings for dyspnoea at submaximal exercise were measured. RESULTS--Static lung compliance, whether expressed as % total lung capacity (TLC)/cm H2O or % predicted TLC/cm H2O, was unrelated to NYHA class. Similarly, there was no relation between static lung compliance and exercise capacity with either protocol or with Borg ratings for dyspnoea at submaximal exercise, with the exception of that measured after 11 minutes of the staged protocol. CONCLUSIONS--Static lung compliance at rest has no relation with treadmill exercise capacity in chronic heart failure, and its relation with measures of dyspnoea is variable. No role for lung elasticity in determining the symptomatology of chronic heart failure was found.Keywords
This publication has 16 references indexed in Scilit:
- Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.Thorax, 1995
- Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.Thorax, 1995
- Clinical pharmacology of long-acting β-receptor agonistsLife Sciences, 1993
- Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilatorLife Sciences, 1993
- Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.Thorax, 1993
- Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.Thorax, 1993
- Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.British Journal of Clinical Pharmacology, 1989
- Catecholamine Modulation of Rapid Potassium Shifts during ExerciseNew England Journal of Medicine, 1985
- β-Adrenoceptor Subtypes in Human, Rat, Guinea Pig, and Rabbit AtriaJournal of Cardiovascular Pharmacology, 1984
- Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on β-adrenoceptors in guinea-pig tracheaEuropean Journal of Pharmacology, 1978